Д.К. Махкамова

Работ: 6

Tashkent Institute of Postgraduate Medical Education, 51 Parkent St., Tashkent, Uzbekistan, 100009

1. Etiopathogenesis of ocular ischemic syndrome

   Д.К. Махкамова

   Обзорная статьяCerebrovascular and Carotid Artery DiseasesRussian Annals of Ophthalmology2017Цитирований: 1

   ABIABI:AkademIndex/openalex/2017.review-article.000009

2. LEVEL OF MARKERS OF NEURODEGENERATION IN PATIENTS WITH OCULAR ISCHEMIC SYNDROME

   H. M. Kamilov, Munirahon Kasimova, Д.К. Махкамова

   СтатьяNeurological Disorders and TreatmentsEuropean Medical Health and Pharmaceutical Journal2014Цитирований: 0

   ABIABI:AkademIndex/openalex/2014.article.000504

3. EVALUATING THE EFFECTIVENESS OF FRUCTOSE-1,6-DIPHOSPHATE IN TREATING OF OCULAR ISCHEMIC SYNDROME

   Д.К. Махкамова

   СтатьяCerebrovascular and Carotid Artery DiseasesEuropean Medical Health and Pharmaceutical Journal2015Цитирований: 0

   ABIABI:AkademIndex/openalex/2015.article.000647

4. Analysis of choline alfoscerate effectiveness in chronic ocular ischemic syndrome

   Х. М. Камилов, М.С. Касимова, Д.К. Махкамова

   СтатьяNeurological Disorders and TreatmentsRussian Annals of Ophthalmology2016Цитирований: 0

   ABIABI:AkademIndex/openalex/2016.article.000349

5. Рenetrating operations of the eyeball as triggering factor of ocular ischemic syndrome

   Д.К. Махкамова

   СтатьяCerebrovascular and Carotid Artery DiseasesOphthalmology in Russia2016Цитирований: 0

   ABIABI:AkademIndex/openalex/2016.article.000543

6. Short-term efficacy of a monoclonal antibody fragment (brolucizumab) for treating neovascular age-related macular degeneration

   A.F. Yusupov, М.Х. Каримова, Sh.A. Djamalova +5

   СтатьяRetinal Diseases and TreatmentsOftalmologicheskii Zhurnal2024Цитирований: 0

   ABIABI:AkademIndex/openalex/2024.article.007191